The WHO has endorsed innovative, portable, and cost-effective TB diagnostics, including point-of-care tests and alternative sample collection methods like tongue swabs and sputum pooling, to improve accessibility and speed of diagnosis.
These new diagnostic guidelines are crucial for accelerating TB detection and treatment, especially in resource-limited settings, and are vital for sustaining progress against TB amidst threats of funding cuts.
Beyond TB, the multi-disease applicability of these new diagnostic tools for conditions like HIV and HPV could significantly enhance patient-centered care and strengthen global health security by streamlining testing processes.

Atlas AI
A global health organization has issued new tuberculosis (TB) guidance recommending point-of-care diagnostic tests and alternative ways to collect samples, aiming to speed up detection and treatment.
The guidelines highlight portable, battery-powered tests that can be used closer to patients rather than relying only on centralized laboratories. Officials said the tests are designed to deliver results within an hour and to cost less than half of many existing molecular diagnostics, a feature intended to support wider use in settings with limited resources.
WHO Endorsement to Accelerate Global TB Diagnostics and Accessibility
The World Health Organization (WHO) has endorsed new rapid diagnostic tests for tuberculosis (TB), including portable point-of-care devices and alternative sample collection methods like tongue swabs. This initiative aims to reduce the cost and turnaround time for TB diagnosis from days to under an hour, significantly enhancing access to testing in resource-limited settings worldwide.
The guidance also expands options for sample collection by endorsing tongue swab samples for people who cannot produce sputum. In addition, it recommends a sputum pooling strategy that combines samples from multiple individuals. The organization said pooling can reduce commodity costs and machine time, which may be particularly relevant where budgets, supplies, and laboratory capacity are constrained.
These recommendations are framed as part of efforts to address TB as a leading infectious cause of death. The organization said faster diagnosis can help shorten delays between infection, confirmation, and treatment, which is central to limiting severe illness and onward transmission.
The guidelines arrive alongside a warning on financing risks. The organization said global efforts against TB have saved an estimated 83 million lives since 2000, but it also cautioned that funding cuts could undermine those gains. The statement links the push for more accessible diagnostics with the need to protect progress made over more than two decades.
The organization also pointed to broader utility for the . It said this multi-disease capability could support more patient-centered diagnostics and strengthen health security by enabling systems to use similar platforms across multiple public health priorities.
